The American Journal of Medicine
Volume 122, Issue 11 , Pages 1023-1028 , November 2009

Risk Factors for Heart Failure: A Population-Based Case-Control Study

  • Shannon M. Dunlay, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn
    • ,
  • Susan A. Weston, MS

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic, Rochester, Minn
    • ,
  • Steven J. Jacobsen, MD, PhD

      Affiliations

    • Southern California Permanente Group, Pasadena
    • ,
  • Véronique L. Roger, MD, MPH

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn
    • Department of Health Sciences Research, Mayo Clinic, Rochester, Minn
    • Corresponding Author InformationReprint requests should be addressed to Véronique L. Roger, MD, MPH, Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905

References 

  1. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397–1402
  2. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292:344–350
  3. Chen YT, Vaccarino V, Williams CS, et al. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med. 1999;106:605–612
  4. He J, Ogden LG, Bazzano LA, et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001;161:996–1002
  5. Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol. 2000;35:1628–1637
  6. Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557–1562
  7. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–313
  8. Melton LJ. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266–274
  9. Ho KK, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107–115
  10. Phillips SJ, Whisnant JP, O'Fallon WM, Frye RL. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc. 1990;65:344–359
  11. Roger VL, Killian J, Henkel M, et al. Coronary disease surveillance in Olmsted County objectives and methodology. J Clin Epidemiol. 2002;55:593–601
  12. Khan M, O'Fallon WM, Sicks J, Whisnant JP. Attributable risk. In: Technical Report No. 54. Rochester, MN: Mayo Clinic; 1995;
  13. Benichou J. Methods of adjustment for estimating the attributable risk in case-control studies: a review. Stat Med. 1991;10:1753–1773
  14. Ali AS, Rybicki BA, Alam M, et al. Clinical predictors of heart failure in patients with first acute myocardial infarction. Am Heart J. 1999;138:1133–1139
  15. Perseghin G, Ntali G, De Cobelli F, et al. Abnormal left ventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance. Diabetes Care. 2007;30:1520–1526
  16. Peterson LR, Herrero P, Schechtman KB, et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation. 2004;109:2191–2196
  17. Lapu-Bula R, Ofili E. From hypertension to heart failure: role of nitric oxide-mediated endothelial dysfunction and emerging insights from myocardial contrast echocardiography. Am J Cardiol. 2007;99:7D–14D
  18. Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation. 2005;111:2837–2849
  19. Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry (The Framingham Heart Study). JAMA. 1991;266:231–236
  20. Ong KL, Cheung BM, Wong LY, et al. Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004. Ann Epidemiol. 2008;18:222–229
  21. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549–1555
  22. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723–1727
  23. Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J. 1994;72:S3–S9
  24. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356:2388–2398
  25. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–e146
  26. Nemetz PN, Roger VL, Ransom JE, et al. Recent trends in the prevalence of coronary disease: a population-based autopsy study of nonnatural deaths. Arch Intern Med. 2008;168:264–270
  27. Arciero TJ, Jacobsen SJ, Reeder GS, et al. Temporal trends in the incidence of coronary disease. Am J Med. 2004;117:228–233
  28. Goldberg RJ, McCormick D, Gurwitz JH, et al. Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol. 1998;82:1311–1317
  29. Fox KA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA. 2007;297:1892–1900
  30. Hellermann JP, Goraya TY, Jacobsen SJ, et al. Incidence of heart failure after myocardial infarction: is it changing over time?. Am J Epidemiol. 2003;157:1101–1107
  31. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med. 2004;164:2126–2134
  32. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251–259
  33. Meissner I, Whisnant JP, Sheps SG, et al. Detection and control of high blood pressure in the community: do we need a wake-up call?. Hypertension. 1999;34:466–471
  34. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572
  35. Grundy SM, Garber A, Goldberg R, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors. Circulation. 2002;105:e153–e158
  36. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93:1137–1146
  37. Curtis LH, Whellan DJ, Hammill BG, et al. Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med. 2008;168:418–424

 Funding: National Institutes of Health Ruth L. Kirschstein National Research Service Award (T32 HL07111-31A1) to Dr Dunlay. American Heart Association Postdoctoral Fellowship Award to Dr Dunlay. National Institutes of Health RO1 (HL72435) to Dr Roger. This study was made possible by the Rochester Epidemiology Project (Grant #R01-AR30582 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases).

 Conflict of Interest: Dr Jacobsen has received research funding from and served as an unpaid consultant to Merck Research Laboratories, but there is no relationship to the present study.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(09)00578-6

doi: 10.1016/j.amjmed.2009.04.022

The American Journal of Medicine
Volume 122, Issue 11 , Pages 1023-1028 , November 2009

Article Tools